Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

MYeloma Resistance And Clonal Evolution

NCT03807128

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: La Roche sur Yon Hospital Departmental La Roche-sur-Yon, France

Nantes University Hospital Nantes, France

View Trial Details

Recruiting

A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

NCT06976437

Conditions: B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China

View Trial Details

Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

NCT06871176

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Recruiting

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

NCT05618041

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Shanxi Bethune Hospital Taiyuan, Shanxi, China

View Trial Details

Recruiting

Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma

NCT07032129

Conditions: Autoimmune Diseases, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

NCT06087653

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Regional Oncology Center Wilson, North Carolina, United States

Gabrail Cancer & Research Center Canton, Ohio, United States

View Trial Details

Recruiting

Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection

NCT07028970

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Peking University First Hospital Beijing, China

People's Hospital of Peking Universit Beijing, China

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China

Tianjin Medical University General Hospital Tianjin, China

View Trial Details

Recruiting

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT06550427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Recruiting

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

NCT06409702

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions